 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Jacques Cornet, VP of Strategic Marketing & Business Development
Cedara Software Corp.
905.672.2100 x 2564 jacques.cornet@cedara.com |
|
Media Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
414.977.4254
bethfj@merge.com
|
|
CEDARA SOFTWARE ANNOUNCES RELEASE OF
NEW .NET DICOM TOOLKIT
- New release of industry leading toolkit, MergeCOM-3™ provides comprehensive DICOM functionality for engineers working in the Microsoft® .NET development environment.
- MergeCOM-3 Advanced Integrator’s .NET Toolkit enables rapid application development for software companies interested in creating medical imaging applications.
Toronto, Ontario, October 3, 2006 – Cedara Software, a Merge Healthcare company (Nasdaq: MRGE; TSX: MRG) and a leading independent developer of medical software technologies for the global healthcare market, today announced the release of a new version of its industry-leading DICOM toolkit, MergeCOM-3, which has been redesigned for the Microsoft .NET development environment. Cedara’s MergeCOM-3 toolkit is a unique Software Developers Kit (SDK) that supports flexible DICOM connectivity for software applications.
Previous versions of MergeCOM-3 Advanced Integrator’s Toolkit have been developed to support software development in over 30 operating system/platform combinations, including native JAVA. As a comprehensive toolkit, MergeCOM-3 greatly reduces the time required to bring DICOM-conformant products to market in any area of medical technology because it enables developers to focus on their application program logic rather than specific details of the DICOM protocol.
MergeCOM-3’s Application Programmer's Interface (API) provides a simple, high-level abstraction of DICOM messaging details, as well as a comprehensive collection of sample applications to demonstrate programming concepts that can serve as a starting point to accelerate development.
“I think the engineering community will be very pleased with our new version of MergeCOM-3,” said Peter Bascom, VP of Engineering at Cedara. “In software development, engineers are generally divided into two camps – those who are diehard supporters of .NET and those who are not. With this new release, a broader community of developers will be able to use Cedara’s leading edge tools for DICOM connectivity, which will accelerate their software development projects.”
Similar to Cedara’s Native Java Toolkit version of MergeCOM-3, the .NET version is an object-oriented class library modeled after objects contained in the DICOM standard. A modern design maximizes performance on a wide array of platforms supported by .NET. Use of .NET minimizes the development learning curve and simplifies application portability across a wide variety of platforms.
With over 20 years of experience in custom engineering and software development, Cedara has created a variety of development tools for OEM medical technology companies. Cedara’s solutions include a library of products to support rapid application development including solutions for DICOM and HL7 connectivity, 3D imaging, registration and segmentation, as well as comprehensive product development platforms.
“As a leading independent provider of medical imaging technologies, we are strongly committed to developing powerful and flexible solutions to the healthcare community,” continued Bascom. “From an OEM development perspective, this means flexible products that can easily accommodate different languages, platforms and engineering tools; from an end-user perspective, this means flexible products that are vendor-independent and can be integrated with any existing technology.”
As a long-term member of the DICOM Standards Committee (as well as IHE and ACR/NEMA), Cedara reviews MergeCOM-3 releases biannually for DICOM protocol and definition updates, and makes upgrades transparent to software developers. Cedara’s connectivity solutions are used widely throughout the medical industry, providing key interoperability to major global healthcare companies and organizations.
###
Cedara Software is a Merge Healthcare company focused on the development of custom engineered software applications and development tools for the medical imaging OEM and International markets. Cedara software is deployed in hospitals and clinics worldwide, and is licensed by many of the world's leading medical device and healthcare information technology companies. Cedara technologies and expertise span all the major digital imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Cedara medical imaging offerings are used in all aspects of clinical imaging workflow including the capture of a patient's digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and the use of imaging in minimally-invasive surgery. For additional information, visit our website at www.cedara.com.
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. With over twenty years of leadership in the medical imaging and healthcare information technology markets, Merge Healthcare provides innovative solutions for both OEM and the end-user healthcare markets. Merge custom engineers clinical and imaging applications and development tools that are on the forefront of medicine and its use of medical imaging for OEM and international customers. In addition, Merge Healthcare develops innovative medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Merge Healthcare’s innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
